According to REGENXBIO's latest financial reports the company has HK$2.15 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-12-31 | $HK$2.01 B | -17.21% |
2023-12-31 | $HK$2.43 B | -39.63% |
2022-12-31 | $HK$4.03 B | -32.33% |
2021-12-31 | $HK$5.95 B | 103.51% |
2020-12-31 | $HK$2.92 B | -16.48% |
2019-12-31 | $HK$3.50 B | -12.01% |
2018-12-31 | $HK$3.98 B | 178.65% |
2017-12-31 | $HK$1.42 B | 14.02% |
2016-12-31 | $HK$1.25 B | -25.36% |
2015-12-31 | $HK$1.68 B | -3902.16% |
2014-12-31 | $-HK$44.2 Million | 165.96% |
2013-12-31 | $-HK$16.62 Million |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | HK$1.72 B | -19.86% | ๐บ๐ธ USA |